Intensified anti-retroviral therapy

被引：1

作者：

Rodríguez-Rosado, R ^{[1
]}

Soriano, V ^{[1
]}

机构：

[1] Inst Salud Carlos III, Hosp Carlos III, Serv Enfermedades Infecciosas, Madrid, Spain

来源：

REVISTA CLINICA ESPANOLA | 2000年 / 200卷 / 02期

关键词：

D O I：

10.1016/S0014-2565(00)70569-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：84 / 87

页数：4

共 23 条

[1] Antiretroviral therapy for HIV infection in 1998 - Updated recommendations of the International AIDS Society USA panel [J].

Carpenter, CCJ ;

Fischl, MA ;

Hammer, SM ;

Hirsch, MS ;

Jacobsen, DM ;

Katzenstein, DA ;

Montaner, JSG ;

Richman, DD ;

Saag, MS ;

Schooley, RT ;

Thompson, MA ;

Vella, S ;

Yeni, PG ;

Volberding, PA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (01) :78-86

[2] Higher antiviral activity of antiretroviral regimens including protease inhibitors [J].

de Mendoza, C ;

Soriano, V ;

Rodríguez-Rosado, R ;

González-Lahoz, J .

AIDS, 1999, 13 (08) :998-999

[3]

Gómez-Cano M, 1998, AIDS, V12, P964

[4] Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy [J].

Havlir, DV ;

Marschner, IC ;

Hirsch, MS ;

Collier, AC ;

Tebas, P ;

Bassett, RL ;

Ioannidis, JPA ;

Holohan, MK ;

Leavitt, R ;

Boone, G ;

Richman, DD .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (18) :1261-1268

[5] The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir [J].

Kempf, DJ ;

Rode, RA ;

Xu, Y ;

Sun, E ;

Heath-Chiozzi, ME ;

Valdes, J ;

Japour, AJ ;

Danner, S ;

Boucher, C ;

Molla, A ;

Leonard, JM .

AIDS, 1998, 12 (05) :F9-F14

[6] Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry [J].

Kilby, JM ;

Hopkins, S ;

Venetta, TM ;

DiMassimo, B ;

Cloud, GA ;

Lee, JY ;

Alldredge, L ;

Hunter, E ;

Lambert, D ;

Bolognesi, D ;

Mathews, T ;

Johnson, MR ;

Nowak, MA ;

Shaw, GM ;

Saag, MS .

NATURE MEDICINE, 1998, 4 (11) :1302-1307

[7]

Kim AE, 1998, J PHARMACOL EXP THER, V286, P1439

[8] Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study [J].

Ledergerber, B ;

Egger, M ;

Opravil, M ;

Telenti, A ;

Hirschel, B ;

Battegay, M ;

Vernazza, P ;

Sudre, P ;

Flepp, M ;

Furrer, H ;

Francioli, P ;

Weber, R .

LANCET, 1999, 353 (9156) :863-868

[9] HYDROXYUREA AS AN INHIBITOR OF HUMAN IMMUNODEFICIENCY VIRUS-TYPE-1 REPLICATION [J].

LORI, F ;

MALYKH, A ;

CARA, A ;

SUN, D ;

WEINSTEIN, JN ;

LISZIEWICZ, J ;

GALLO, RC .

SCIENCE, 1994, 266 (5186) :801-805

[10] Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1 [J].

Martinez-Picado, J ;

Savara, LV ;

Sutton, L ;

D'Aquila, RT .

JOURNAL OF VIROLOGY, 1999, 73 (05) :3744-3752

← 1 2 3 →